Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Income towards Parent Company (2010 - 2026)

Geron (GERN) posted Income towards Parent Company of -$3.6 million for Q1 2026, up 87.61% sequentially from -$28.8 million in Q4 2025, and up 81.94% YoY from -$2.0 million in Q1 2025.

Geron (GERN) Income towards Parent Company (2010 - 2026) Analysis & Trends

Geron has reported Income towards Parent Company for 17 years, with the latest figure at -$3.6 million in Q1 2026.

  • Quarterly Income towards Parent Company rose 81.94% year-over-year to -$3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.9 million (up 51.16% YoY) and the FY2025 annual result came in at -$495.1 million, up 15.23% from the prior year.
  • Income towards Parent Company advanced to -$3.6 million in Q1 2026 per GERN's latest filing, from -$28.8 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$3.6 million in Q1 2026 and troughed at -$67.3 million in Q2 2024.
  • A 5-year average of -$34.4 million and a median of -$30.7 million in 2022 frame the typical range for Income towards Parent Company.
  • The sharpest annual moves came in 2023 and 2026: Income towards Parent Company tumbled 68.39% in 2023, then soared 81.94% in 2026.
  • Over 5 years, Income towards Parent Company stood at -$41.0 million in 2022, then decreased by 23.73% to -$50.7 million in 2023, then surged by 53.48% to -$23.6 million in 2024, then retreated by 22.02% to -$28.8 million in 2025, then soared by 87.61% to -$3.6 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$3.6 million, -$28.8 million, and -$18.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Geron 1.02 Mn -299.83 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.67 Mn
Mar 31, 2026 -3.57 Mn
Dec 31, 2025 -28.79 Mn
Sep 30, 2025 -18.27 Mn
Jun 30, 2025 -16.31 Mn
Mar 31, 2025 -19.75 Mn
Dec 31, 2024 -23.60 Mn
Sep 30, 2024 -26.38 Mn
Jun 30, 2024 -67.32 Mn
Mar 31, 2024 -55.33 Mn
Dec 31, 2023 -50.72 Mn
Sep 30, 2023 -44.71 Mn
Jun 30, 2023 -49.22 Mn
Mar 31, 2023 -38.16 Mn
Dec 31, 2022 -40.99 Mn
Sep 30, 2022 -40.91 Mn
Jun 30, 2022 -29.23 Mn
Mar 31, 2022 -30.69 Mn
Dec 31, 2021 -30.98 Mn
Sep 30, 2021 -26.62 Mn